Lv1
50 积分 2024-04-10 加入
[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2022 edition)]
5小时前
待确认
Non–Small Cell Lung Cancer, Version 4.2024
5小时前
已完结
CTCAE versión 5.0. Evaluación de la gravedad de los eventos adversos dermatológicos de las terapias antineoplásicas
6小时前
已完结
The Role of Biologically Effective Dose (BED) in Clinical Oncology
1个月前
已完结
Thoracic Radiotherapy Improves the Survival in Patients With EGFR -Mutated Oligo-Organ Metastatic Non–Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors: A Multicenter, Randomized, Controlled, Phase III Trial
1个月前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
1个月前
已完结
鼻咽癌适形调强放射治疗(IMRT)的质量保证
3个月前
已完结
Radiation pneumonitis after concurrent aumolertinib and thoracic radiotherapy in EGFR-mutant non-small cell lung cancer patients
5个月前
已完结
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
5个月前
已完结
Clinical and dosimetric characteristics of temporal lobe injury following intensity modulated radiotherapy of nasopharyngeal carcinoma
7个月前
已完结
皖公网安备34019202002308
